Related Experiment Videos
A decade of changing perceptions about neuropeptides.
A J Kastin1, W A Banks, J E Zadina
1Veterans Administration Medical Center, University of New Orleans, Louisiana.
Annals of the New York Academy of Sciences
|January 1, 1990
Summary
Neuropeptide research has advanced, exploring if peptides cross the blood-brain barrier. Tyr-MIF-1, an endogenous antiopiate peptide, exemplifies these evolving scientific concepts.
Area of Science:
- Neuroscience
- Peptide Science
Background:
- Recent decade shows significant growth in neuropeptide research.
- Development of novel concepts, including peptide transport across the blood-brain barrier (BBB).
Observation:
- Tyr-MIF-1, an endogenous brain peptide, served as a prototype for BBB crossing.
- Tyr-MIF-1 also investigated for endogenous antiopiate neuropeptide activity.
Findings:
- Initial skepticism is common for groundbreaking scientific concepts.
- Over time, initial challenges are often forgotten, facilitating concept acceptance.
Implications:
- Understanding neuropeptide BBB transport is crucial for neuropharmacology.
- The history of Tyr-MIF-1 research highlights the evolution of scientific acceptance.